The FDA’s Division of Drug Marketing, Advertising and Communications (“DDMAC”) issued four warning letters and two untitled letters from January through April 2007. The six letters address a wall calendar and dry erase board, a journal advertisement, a direct-to-consumer television advertisement, a retail sell sheet, a sales aid, and a physician’s presentation and hand-out to the Maryland Department of Health and Mental Hygiene’s Pharmacy and Therapeutics Committee.
Please click here to read the full article.